Skip to main content
. Author manuscript; available in PMC: 2020 Jan 6.
Published in final edited form as: Integr Biol (Camb). 2013 Jan;5(1):29–42. doi: 10.1039/c2ib20047c

Figure 3. Male ICR mice bearing a subcutaneous H22 (murine hepatoma cell line) tumor at the left side of the thorax.

Figure 3.

A) Coronal images of a mouse in the control group (saline). B) Coronal images of a mouse in the group receiving intratumoral free cisplatin (5 mg/kg). C) Coronal images of a mouse in the group receiving intratumoral cisplatin-loaded nanoparticles (5 mg/kg). Reproduced from Li et al.28